Doxazosin Mesylate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 12 USDMF, 9 CEP/COS, 7 JDMF, 8 EU WC, 6 KDMF, 8 NDC API, 19 Listed Suppliers, $ API Reference Price

INTERMEDIATES

17 Intermediates Suppliers

17 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

349 FDF Dossiers, 82 FDA Orange Book, 219 Europe, 12 Canada, 9 South Africa, 27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 1MG BASE, TABLET;ORAL - EQ 2MG BASE, TABLET;ORAL - EQ 4MG BASE, TABLET;ORAL - EQ 8MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 4MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 8MG BASE

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Seqens, 4 DKSH, 1 Jai Radhe Sales, 5 Faran Shimi Pharmaceutical, 12 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 15 BASF, 10 Corel Pharma Chem, 7 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 31 Direct Compression, 28 Disintegrants & Superdisintegrants, 25 Controlled & Modified Release, 21 Granulation, 18 Thickeners and Stabilizers, 15 Co-Processed Excipients, 14 Lubricants & Glidants, 9 Taste Masking, 8 Topical, 7 Film Formers & Plasticizers, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 Coloring Agents, 5 Solubilizers, 5 Parenteral, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Emulsifying Agents, 3 Rheology Modifiers, 1 Surfactant & Foaming Agents